{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T05:32:23Z","timestamp":1793770343421,"version":"4.6.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,10,19]],"date-time":"2027-10-19T00:00:00Z","timestamp":1823904000000},"content-version":"am","delay-in-days":232,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2027,3]]},"DOI":"10.1016\/j.biomaterials.2026.124699","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:54:11Z","timestamp":1791906851000},"page":"124699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PB","title":["Genetically engineering mast cells as effectors for targeted cancer cell cytotoxicity"],"prefix":"10.1016","volume":"338","author":[{"given":"Xiao","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5755-0554","authenticated-orcid":false,"given":"Ruxing","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0537-5518","authenticated-orcid":false,"given":"Yifan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0313-5819","authenticated-orcid":false,"given":"Zejun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7052-7043","authenticated-orcid":false,"given":"Xiao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jicheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3214-8355","authenticated-orcid":false,"given":"Zhen","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaixin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biomaterials.2026.124699_bib1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00062752-199704010-00006","article-title":"Killing mechanisms of cytotoxic lymphocytes","volume":"4","author":"Berke","year":"1997","journal-title":"Curr. Opin. Hematol."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124699_bib2","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.it.2015.06.004","article-title":"Engineering CAR-T cells: design concepts","volume":"36","author":"Srivastava","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.biomaterials.2026.124699_bib3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.canlet.2019.11.033","article-title":"CAR-NK for tumor immunotherapy: clinical transformation and future prospects","volume":"472","author":"Wang","year":"2020","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124699_bib4","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/ni.f.216","article-title":"New developments in mast cell biology","volume":"9","author":"Kalesnikoff","year":"2008","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124699_bib5","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0952-7915(96)80002-1","article-title":"Downstream signals initiated in mast cells by Fc\u03b5RI and other receptors","volume":"8","author":"Beaven","year":"1996","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124699_bib6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3389\/fimmu.2014.00569","article-title":"Mast cell mediators: their differential release and the secretory pathways involved","volume":"5","author":"Moon","year":"2014","journal-title":"Front. Immunol."},{"issue":"6493","key":"10.1016\/j.biomaterials.2026.124699_bib7","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1126\/science.aay9207","article-title":"Supramolecular attack particles are autonomous killing entities released from cytotoxic T cells","volume":"368","author":"B\u00e1lint","year":"2020","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124699_bib8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.immuni.2005.08.001","article-title":"Perforin triggers a plasma membrane-repair response that facilitates CTL induction of apoptosis","volume":"23","author":"Keefe","year":"2005","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124699_bib9","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/febs.13649","article-title":"Serglycin determines secretory granule repertoire and regulates natural killer cell and cytotoxic T lymphocyte cytotoxicity","volume":"283","author":"Sutton","year":"2016","journal-title":"FEBS J."},{"issue":"39","key":"10.1016\/j.biomaterials.2026.124699_bib10","doi-asserted-by":"crossref","first-page":"40897","DOI":"10.1074\/jbc.M405856200","article-title":"Serglycin is essential for maturation of mast cell secretory granule","volume":"279","author":"\u00c5brink","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"25","key":"10.1016\/j.biomaterials.2026.124699_bib11","doi-asserted-by":"crossref","first-page":"7406","DOI":"10.1021\/bi9928391","article-title":"Conformation of the isolated C\u03b53 domain of IgE and its complex with the high-affinity receptor, Fc\u03b5RI","volume":"39","author":"Henry","year":"2000","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124699_bib12","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.cell.2025.11.015","article-title":"Sensitized mast cells for targeted drug delivery and augmented cancer immunotherapy","volume":"189","author":"Xu","year":"2026","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124699_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1179\/2046023611Y.0000000006","article-title":"Differential staining of mast cells with toluidine blue","volume":"35","author":"Broome","year":"2012","journal-title":"J. Histotechnol."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124699_bib14","first-page":"3861","article-title":"Marked increase in CC chemokine gene expression in both human and mouse mast cell transcriptomes following Fc\u03b5 receptor I cross-linking: an interspecies comparison","volume":"100","author":"Nakajima","year":"2002","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"18","key":"10.1016\/j.biomaterials.2026.124699_bib15","doi-asserted-by":"crossref","first-page":"6467","DOI":"10.1073\/pnas.0501912102","article-title":"Mast cells enhance T cell activation: importance of mast cell-derived TNF","volume":"102","author":"Nakae","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124699_bib16","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/cyto.a.20068","article-title":"LAMP\u20101 and LAMP\u20102, but not LAMP\u20103, are reliable markers for activation\u2010induced secretion of human mast cells","volume":"61","author":"Gr\u00fctzkau","year":"2004","journal-title":"Cytom. J. Int. Soc. Anal. Cytol."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124699_bib17","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.jaci.2021.08.019","article-title":"IgE cross-linking induces activation of human and mouse mast cell progenitors","volume":"149","author":"M\u00e9ndez-Enr\u00edquez","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124699_bib18","doi-asserted-by":"crossref","first-page":"6174","DOI":"10.1038\/ncomms7174","article-title":"Mast cells form antibody-dependent degranulatory synapse for dedicated secretion and defence","volume":"6","author":"Joulia","year":"2015","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124699_bib19","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1084\/jem.20101757","article-title":"Differential regulation of mast cell degranulation versus cytokine secretion by the actin regulatory proteins Coronin1a and Coronin1b","volume":"208","author":"F\u00f6ger","year":"2011","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124699_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-6968.2004.tb09619.x","article-title":"Mechanisms of G protein-coupled receptor-mediated degranulation","volume":"236","author":"Vines","year":"2004","journal-title":"FEMS Microbiol. Lett."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124699_bib21","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.pt.2008.03.006","article-title":"Helminths and allergy: the example of tropomyosin","volume":"24","author":"Sereda","year":"2008","journal-title":"Trends Parasitol."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124699_bib22","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1083\/jcb.102.6.2185","article-title":"Contact-induced redistribution of specific membrane components: local accumulation and development of adhesion","volume":"102","author":"McCloskey","year":"1986","journal-title":"J. Cell Biol."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124699_bib23","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/0092-8674(91)90272-Z","article-title":"A noncytotoxic mast cell tumor line exhibits potent IgE-dependent cytotoxicity after transfection with the cytolysin\/perforin gene","volume":"64","author":"Shiver","year":"1991","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124699_bib24","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/sj.gt.3301433","article-title":"MHC class II presentation of endogenously expressed antigens by transfected dendritic cells","volume":"8","author":"Diebold","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.biomaterials.2026.124699_bib25","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fimmu.2012.00104","article-title":"Roles for Ca2+ mobilization and its regulation in mast cell functions","volume":"3","author":"Holowka","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124699_bib26","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3389\/fimmu.2018.00684","article-title":"Imaging polarized secretory traffic at the immune synapse in living T lymphocytes","volume":"9","author":"Calvo","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124699_bib27","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3389\/fimmu.2018.00307","article-title":"Signals controlling lytic granule polarization at the cytotoxic immune synapse","volume":"9","author":"Kabanova","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124699_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.629097","article-title":"Role of actin cytoskeleton reorganization in polarized secretory traffic at the immunological synapse","volume":"9","author":"Calvo","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124699_bib30","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1083\/jcb.115.6.1491","article-title":"Characterization of the immature secretory granule, an intermediate in granule biogenesis","volume":"115","author":"Tooze","year":"1991","journal-title":"J. Cell Biol."},{"issue":"14","key":"10.1016\/j.biomaterials.2026.124699_bib31","first-page":"2659","article-title":"Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attack","volume":"121","author":"Lopez","year":"2013","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"6591","key":"10.1016\/j.biomaterials.2026.124699_bib32","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1126\/science.abl3855","article-title":"ESCRT-mediated membrane repair protects tumor-derived cells against T cell attack","volume":"376","author":"Ritter","year":"2022","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124699_bib33","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1038\/sj.cdd.4402183","article-title":"Granzyme B is expressed in mouse mast cells in vivo and in vitro and causes delayed cell death independent of perforin","volume":"14","author":"Pardo","year":"2007","journal-title":"Cell Death Differ."},{"issue":"14","key":"10.1016\/j.biomaterials.2026.124699_bib34","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1016\/j.molimm.2007.03.024","article-title":"Human mast cells produce and release the cytotoxic lymphocyte associated protease granzyme B upon activation","volume":"44","author":"Strik","year":"2007","journal-title":"Mol. Immunol."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124699_bib35","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.4049\/jimmunol.0902609","article-title":"Induction of Th17 cells in the tumor microenvironment improves survival in a murine model of pancreatic cancer","volume":"185","author":"Gnerlich","year":"2010","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124699_bib36","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000371764","article-title":"CCL2\/CCR2-dependent recruitment of Th17 cells but not Tc17 cells to the lung in a murine asthma model","volume":"166","author":"Wang","year":"2015","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124699_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008922","article-title":"Mast cells mobilize myeloid-derived suppressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma model","volume":"5","author":"Yang","year":"2010","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124699_bib38","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1158\/2326-6066.CIR-17-0385","article-title":"Cross-talk between myeloid-derived suppressor cells and mast cells mediates tumor-specific immunosuppression in prostate cancer","volume":"6","author":"Jachetti","year":"2018","journal-title":"Cancer Immunol. Res."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124699_bib39","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1158\/0008-5472.CAN-09-3690","article-title":"5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell\u2013dependent antitumor immunity","volume":"70","author":"Vincent","year":"2010","journal-title":"Cancer Res."},{"issue":"7_Part_1","key":"10.1016\/j.biomaterials.2026.124699_bib40","first-page":"2406","article-title":"Mechanism of induction of gastrointestinal toxicity in the mouse by 5-fluorouracil, 5-fluorouridine, and 5-fluoro-2\u2032-deoxyuridine","volume":"39","author":"Houghton","year":"1979","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2026.124699_bib41","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.imlet.2019.03.011","article-title":"Mast cells: a double-edged sword in cancer","volume":"209","author":"Derakhshani","year":"2019","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.biomaterials.2026.124699_bib42","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.canlet.2018.07.005","article-title":"The dual role of mast cells in tumor fate","volume":"433","author":"Ribatti","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biomaterials.2026.124699_bib43","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/703163","article-title":"Mast cells positive to tryptase and c-kit receptor expressing cells correlates with angiogenesis in gastric cancer patients surgically treated","volume":"2013","author":"Ammendola","year":"2013","journal-title":"Gastroenterol. Res. Pract."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124699_bib44","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1034\/j.1600-0463.2002.100501.x","article-title":"Mast cells and angiogenesis","volume":"110","author":"Norrby","year":"2002","journal-title":"Apmis"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124699_bib45","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/pros.23280","article-title":"Low intratumoral mast cells are associated with a higher risk of prostate cancer recurrence","volume":"77","author":"Hempel","year":"2017","journal-title":"Prostate"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124699_bib46","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.2353\/ajpath.2010.100070","article-title":"Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy","volume":"177","author":"Johansson","year":"2010","journal-title":"Am. J. Pathol."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226007234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226007234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T05:21:28Z","timestamp":1793769688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961226007234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,3]]},"references-count":45,"alternative-id":["S0142961226007234"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124699","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2027,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetically engineering mast cells as effectors for targeted cancer cell cytotoxicity","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124699","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124699"}}